UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042764
Receipt number R000048801
Scientific Title Effect of feeding black ginger supplement on improvement of cold intolerance
Date of disclosure of the study information 2021/01/13
Last modified on 2021/06/16 10:30:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of feeding black ginger supplement on improvement of cold intolerance

Acronym

Improvement of cold intolerance by feeding black ginger supplement

Scientific Title

Effect of feeding black ginger supplement on improvement of cold intolerance

Scientific Title:Acronym

Effect of feeding black ginger supplement on improvement of cold intolerance

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigate the effects of feeding black ginger supplement on improvement of cold tolerance

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skin surface temperature of fingers and feet

Key secondary outcomes

Vas questionaire
(1)cold intolerance of whole body
(2)cold intolerance of limbs
(3)fatigue
(4)shoulder stiffness
(5)quality of sleep
(6)constipation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

The subjects ingested the placebo meal for 28 days.

Interventions/Control_2

The subjects ingested the active meal for 28 days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

1) Healthy male and female between 20 and 70 years old
2) Individuals who has subjective symptoms of cold intolerance
3) Individuals who can refrain from over drinking and over eating during the test period
4) Individuals who understand the purpose and contents of the experiment

Key exclusion criteria

1)Subjects who are contracting or treating severe diabetes and kidney and/or liver diseases
2)Individuals who have a chronic diseases and regularly use drugs
3)Pregnant women, or women with intending to become pregnant, and lactating woman
4)Individuals participating or intending to participate in a drug administration test
5)Individuals judged by the doctor to be unsuitable

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Kazunari
Middle name
Last name Tanaka

Organization

Univercity of Nagasaki

Division name

Regional Partnership Center

Zip code

8512195

Address

1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195

TEL

0958135216

Email

katanaka@sun.ac.jp


Public contact

Name of contact person

1st name Hideki
Middle name
Last name Ito

Organization

Univercity of Nagasaki

Division name

Regional Partner Center

Zip code

8512195

Address

1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195

TEL

0958135216

Homepage URL


Email

katanaka@sun.ac.jp


Sponsor or person

Institute

Univercity of Nagasaki

Institute

Department

Personal name



Funding Source

Organization

Charle Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Univercity of Nagasaki

Address

1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195

Tel

0958135216

Email

katanaka@sun.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

60

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 01 Month 13 Day

Date of IRB

2020 Year 12 Month 17 Day

Anticipated trial start date

2021 Year 01 Month 13 Day

Last follow-up date

2021 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 12 Month 16 Day

Last modified on

2021 Year 06 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048801


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name